1. Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry 
Paul C. Mayor, MD, Kevin H. Eng, PhD, Kelly L. Singel, BS, Scott I. Abrams, PhD, Kunle Odunsi, MD, PhD, Kirsten B. Moysich, PhD, Ramsay Fuleihan, MD, Elizabeth Garabedian, RN, Patricia Lugar, MD, Hans D. Ochs, MD, Francisco A. Bonilla, MD, PhD, Rebecca H. Buckley, MD, Kathleen E. Sullivan, MD, PhD, Zuhair K. Ballas, MD, Charlotte Cunningham-Rundles, MD, PhD, Brahm H. Segal, MD 
Journal of Allergy and Clinical Immunology 
Volume 141, Issue 3, Pages (March 2018)
DOI: /j.jaci
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Cancer incidence in both men and women in the USIDNET registry as well as age-adjusted cancer incidence obtained from the SEER database in men and women. We used SEER data to create an age-adjusted cancer incidence for the general population in 5-year increments. We applied SEER incidence data and adjusted for age to estimate the expected incidence of cancer.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions